Related by context. All words. (Click for frequent words.) 70 antiangiogenic therapy 70 ZOLINZA 70 alteplase 69 intravenous tissue plasminogen 69 riociguat 69 intravenous cyclophosphamide 68 rFVIIa 68 paricalcitol 68 rt PA 68 tissue plasminogen activator tPA 68 intracoronary 68 MGd 67 antiarrhythmic drugs 67 intravenous tPA 67 oral anticoagulation 67 colorectal liver metastases 67 β blockers 66 circulating EPCs 66 recombinant tissue plasminogen 66 cardiac repolarization 66 pyridostigmine 66 fibrinolytic therapy 66 bolus dose 66 thrombolytic therapy 66 LHRH agonists 66 PROCHYMAL 66 perioperatively 66 TNF alpha antagonist 66 systemically administered 65 recurrent glioblastoma multiforme 65 IFN beta 65 dissolving clots 65 clot busting medication 65 epoetin alpha 65 Hypotension 65 argatroban 65 clot busting therapy 65 infused intravenously 65 N acetylcysteine 65 otamixaban 65 hypotensive 65 IOP lowering 65 nebulization 65 conventional angiography 65 intracerebral haemorrhage 65 thrombotic complications 65 virological response 65 antitumor effect 65 inhibit platelet aggregation 65 Teriflunomide 65 oral rivaroxaban 65 tPA 65 cilostazol 65 antithrombotic therapy 65 busulfan 65 anagrelide 65 interferon therapy 65 TNF antagonist 64 fibrinolytic 64 activator tPA 64 ximelagatran 64 telomerase inhibition 64 cerebral vasospasm 64 fibrinolysis 64 inotropic 64 thrombocytopenic 64 pentoxifylline 64 fosbretabulin 64 nonischemic 64 corticosteroid therapy 64 choroidal vasculopathy 64 fluvastatin 64 drug eluting stent implantation 64 intracerebral 64 VAPRISOL 64 lipid lowering therapy 64 relapsed MM 64 allogeneic HSCT 64 galiximab 64 CYP #A# 64 silent ischemia 64 platelet reactivity 64 antiarrhythmic 64 antiangiogenic agent 64 WBPA 64 aPTT 64 NATRECOR ® 64 plasma kallikrein inhibitor 64 dose escalation phase 64 CINQUIL 64 clot dissolving drug 64 LV dysfunction 64 APTIVUS r 64 artery stenosis 64 bezafibrate 64 VA# [002] 64 OHR/AVR# 64 HIV HCV coinfected 64 stratifying patients 64 systemic hypotension 63 protamine sulfate 63 dissolving blood clots 63 octreotide LAR 63 vasopressor 63 BoNTA 63 Vidaza azacitidine 63 intravenous bisphosphonates 63 thyrotropin 63 Tasigna prolongs 63 HER2 expression 63 ELACYT 63 antiplatelet drugs 63 serum cortisol 63 anticlotting drugs 63 selective modulator 63 dobutamine 63 transdermal estradiol 63 teriflunomide 63 weekly subcutaneous injections 63 flecainide 63 PRADAXA #mg 63 flavopiridol 63 neostigmine 63 neointimal hyperplasia 63 torsade de pointes 63 liver metastasis 63 colorectal cancer liver metastases 63 ß blockers 63 edifoligide 63 tinzaparin 63 NF kappaB activation 63 erythropoietic 63 cisplatin chemotherapy 63 bovine thrombin 63 thalidomide Thalomid 63 clevidipine 63 transrectal ultrasound guided 63 bronchodilation 63 PRADAXA 63 pharmacokinetic interactions 63 clomipramine 63 aldosterone antagonists 63 corticosteroid dexamethasone 63 lymphocyte counts 63 trastuzumab Herceptin ® 63 HBV vaccine 63 surrogate endpoint 63 iloprost 63 Aclidinium 63 icatibant 63 #I TM# 63 ischemia induced 63 ICD shocks 63 Teriparatide 63 etomidate 63 antiplatelet medications 63 DCCR 63 nephrotoxicity 63 IV tPA 63 surgical revascularization 63 cardioprotection 63 GPIIb IIIa 63 intravenous diuretics 63 postoperative AF 63 eptifibatide 63 GHRH 63 angiographically 63 GIST tumors 63 somatostatin analogues 63 dosage regimens 63 bolus injection 63 anti androgen 63 tumorigenicity 63 hepatic arterial 63 eculizumab therapy 63 receptor blocker 63 hMG 63 AGHD 63 olmesartan 63 glomerular filtration 63 platelet inhibition 63 fumagillin nanoparticles 63 streptokinase 63 intratumoral 63 antifibrinolytic 63 EXJADE 62 adrenal suppression 62 androgen ablation 62 urocortin 2 62 gadobutrol 62 thrombolytics 62 acute aortic dissection 62 aspirin clopidogrel 62 KAPVAY ™ 62 endothelial activation 62 recurrent venous thromboembolism 62 oral antidiabetic medication 62 #beta estradiol 62 gefitinib Iressa 62 cardiac troponin 62 sitaxsentan 62 cinacalcet 62 rebleeding 62 sonographic diagnosis 62 cardiac perfusion 62 immunosuppressant drug 62 intensive statin therapy 62 p# activation 62 deferiprone 62 chemoradiation therapy 62 plasminogen activators 62 interferon ribavirin 62 Bosentan 62 postoperative complication 62 malignant ascites 62 ketorolac 62 methotrexate monotherapy 62 CYP#A# inhibitors 62 inhibit platelet function 62 antiretroviral naive 62 Gleevec resistant 62 intradermal injections 62 vWF 62 vivo potency 62 injectable formulations 62 DVT prophylaxis 62 cefazolin 62 Enzastaurin 62 renal cysts 62 upper gastrointestinal bleeding 62 QTc prolongation 62 metastatic uveal melanoma 62 miglustat 62 DFMO 62 radiotherapy RT 62 Hydroxyurea 62 monophasic 62 revascularization procedure 62 lung nodule 62 dalteparin 62 gallium nitrate 62 EGFRIs 62 losartan 62 neuroinflammatory 62 nimodipine 62 5 Fluorouracil 62 ispinesib administered 62 coagulation parameters 62 azacytidine 62 directed thrombolysis 62 Dasatinib 62 tracheal intubation 62 LMWH 62 amifostine 62 tardive dyskinesia TD 62 tumor histology 62 postprocedure 62 hereditary deficiency 62 reinfarction 62 CIMZIA TM 62 neutrophil counts 62 inhaled iloprost 62 inhibiting COX 62 arteriography 62 arterial calcification 62 antiarrhythmic drug 62 immunosuppressant therapy 62 alefacept 62 FXIII 62 blood clot dissolving 62 hepatic toxicity 62 Heavy menstrual bleeding 62 biochemical relapse 62 antithrombotic agents 62 reperfusion therapy 62 BYSTOLIC 62 ICD therapy 62 Natalizumab 62 relapsed ALL 62 pharmacodynamic effects 62 hemodynamically stable 62 lactate dehydrogenase LDH 62 prostanoid 62 antiplatelet therapies 62 iroxanadine 62 hepatotoxic 62 intravenous heparin 62 dose titration 62 posttransplant 62 palivizumab 62 Cell Lymphoma CTCL 62 darbepoetin alpha 62 anticoagulant warfarin 62 nutlin 3a 62 AChE inhibitors 62 somatostatin analogs 62 eplerenone 62 dexrazoxane 62 P selectin 62 paclitaxel eluting stents 62 mecamylamine 62 plasma pharmacokinetics 62 vascular insufficiency 62 COREG 62 AST ALT 62 nicardipine 62 eosinophil count 62 cerebral angiography 62 chemoradiotherapy 62 pharmacodynamic parameters 62 abnormal clotting 62 isoproterenol 62 uridine triacetate 62 Hormonal therapy 62 Subgroup analysis 62 PICSO ® 62 steroid dexamethasone 62 Bezielle 62 MAGE A3 ASCI 62 daily subcutaneous injections 61 mutated K ras 61 HPA axis suppression 61 resynchronization therapy 61 intravenous dosing 61 PlGF 61 #mg ATC 61 unruptured aneurysm 61 KAPIDEX 61 cranial irradiation 61 hyperacute 61 urothelial cancer 61 invasive aspergillosis 61 NAbs 61 Degarelix 61 prostate cancer metastases 61 receptor inhibitor 61 anthracycline chemotherapy 61 glucocorticoid therapy 61 anticoagulant medication 61 intravenous IV infusion 61 Ophena TM 61 leflunomide 61 MMP inhibitor 61 adrenalectomy 61 BETAS 61 intracranial hemorrhage ICH 61 radioiodine therapy 61 antifibrotic 61 variceal bleeding 61 amyloid plaque formation 61 glycoprotein IIb IIIa inhibitor 61 mitochondrial toxicity 61 serum calcium levels 61 tenecteplase 61 antimicrobial prophylaxis 61 DaTscan 61 H2 antagonists 61 Aggrastat ® tirofiban hydrochloride 61 catheter angiography 61 adjuvant radiotherapy 61 Afib 61 antiresorptive 61 uricase 61 metastatic malignant 61 divalproex sodium 61 convenient dosing regimens 61 aurora kinase 61 BENICAR HCT 61 unresectable tumors 61 mediated inhibition 61 antithrombotic 61 thienopyridines 61 vascular thrombosis 61 neointimal 61 dose atorvastatin 61 anti angiogenic agents 61 activator rt PA 61 intermittent dosing 61 efaproxiral 61 factor Xa 61 PROMACTA 61 hyperalgesia 61 recanalization 61 serum phosphorous 61 haemodynamic 61 aminotransferase 61 hypofractionated radiation 61 administered systemically 61 mTOR inhibitors 61 beta blocker therapy 61 haematologic 61 apneic episodes 61 GnRH agonists 61 primary aldosteronism 61 renoprotective 61 prolongs survival 61 carotid plaque 61 platelet activation 61 ATACAND 61 neurologic progression 61 symptomatic paroxysmal AF 61 alpha fetoprotein AFP 61 prophylactic cranial irradiation 61 lesional 61 antibody titer 61 fulvestrant 61 E selectin 61 defibrillator implant 61 methotrexate therapy 61 coagulation abnormalities 61 Gliadel Wafer 61 Febrile neutropenia 61 gastrointestinal stromal tumors GIST 61 Aliskiren 61 β blocker 61 CYT# QbG# 61 MP4OX 61 Bivalirudin 61 platelet inhibitor 61 diabetic gastroparesis 61 antiplatelet medication 61 HbF 61 noscapine 61 preoperative chemotherapy 61 bleomycin 61 thromboembolic events 61 intraperitoneally 61 Adjuvant chemotherapy 61 MDCT angiography 61 intravenously administered 61 hypericin 61 ADAGIO study 61 pharmacokinetic characteristics 61 cardiotoxic 61 verteporfin 61 receptor tyrosine kinase inhibitor 61 denileukin diftitox 61 Insulin detemir 61 flutamide 61 troponins 61 Lisofylline 61 prolonged QT interval 61 extubation 61 B7 H3 61 pamidronate 61 platelet dysfunction 61 prehospital setting 61 pharmacologic intervention 61 renal toxicity 61 subconjunctival injection 61 Intravenous immunoglobulin 61 immune modulating 61 prostate carcinoma 61 Akt activation 61 PSA nadir 61 neuroleptic 61 bortezomib Velcade 61 sipuleucel T 61 MULTAQ 61 intensive lipid lowering 61 abacavir lamivudine 61 selenium supplementation 61 dissolves blood clots 61 Kinoid 61 microglial activation 61 plasma kallikrein 61 Inhaled nitric oxide 61 poor metabolizers 61 PLX STROKE targeting 61 myocardial necrosis 61 underwent angiography 61 Coronary CTA 61 aromatase inhibitor therapy 61 samalizumab 61 radiolabeled TM# 61 INVEGA ® 61 percutaneous biopsy 61 tumor regressions 61 oral methylnaltrexone 61 isradipine 61 experimentally induced 61 carotid artery blockage 61 tPA tissue plasminogen 61 hydroxychloroquine 61 EDARBI 61 antibiotic prophylaxis 61 anticholinergic agents 61 biomarker assay 61 dosing frequency 61 null responder 61 Interferon alpha 61 #mg dose [001] 61 EGFR TKI 61 hemodynamic variables 61 neuroregenerative 61 mycophenolate mofetil MMF 61 Known hypersensitivity 61 lactate dehydrogenase 61 electrical cardioversion 61 tryptase 61 insulin sensitizing 61 GnRH agonist 61 percutaneous drainage 61 hemodilution 61 myocyte 61 ancrod 61 Venous thromboembolism 61 papillary renal cell carcinoma 61 visilizumab 61 alkylating agent 61 mesalamine granules 61 anterior uveitis 61 unstable angina UA 61 intravenous bolus 61 EVIZON 61 systemic toxicity 61 tegaserod 61 thrombolytic agents 61 hsCRP levels 61 anthracycline therapy 61 corrected QT interval 61 Losartan 61 ziconotide 61 dose proportionality 61 vitamin D analogs 61 chronic thromboembolic pulmonary 61 HCV replicon 61 transarterial 61 Thrombotic thromboembolic complications 61 RISPERDAL ® 61 thyroid hormone replacement 61 GP IIb IIIa inhibitors 61 underwent coronary angiography 61 Temsirolimus 61 aminotransferases 61 Doxil ® 60 antiplatelet agent 60 virologic responses 60 Anticoagulants 60 leukocyte count 60 HER2 overexpression 60 pegylated alpha interferon 60 Tranexamic acid 60 opioid analgesia 60 thienopyridine 60 curative therapy 60 nanomolar range 60 desvenlafaxine succinate 60 hepatorenal syndrome 60 myopathy rhabdomyolysis 60 Paliperidone 60 molecular remissions 60 factor Xa inhibitor 60 ritonavir boosted 60 tissue oxygenation 60 thyroid carcinoma 60 urography 60 oral anticoagulant therapy 60 adjuvant cisplatin 60 elective PCI 60 thoracoscopic lobectomy 60 chemopreventive agent 60 rhGH 60 DAPT 60 weekly intravenous infusions 60 cilengitide 60 lipid lowering therapies 60 verapamil 60 LT NS# 60 vasodilators 60 INTEGRILIN R 60 PSADT 60 inotropes 60 FFR measurements 60 metastatic lesion 60 canakinumab 60 bisoprolol 60 macrolide antibiotic 60 immunosuppressive regimen 60 antirheumatic 60 alfuzosin 60 r hGH 60 decitabine 60 antiangiogenesis 60 mycophenolate mofetil 60 dual endothelin receptor antagonist 60 NATRECOR R 60 GLP1 agonist 60 Vimpat R 60 allograft rejection 60 interferon beta therapy 60 Dacogen decitabine 60 ablative therapy 60 antimuscarinic 60 bronchoalveolar lavage fluid 60 acetazolamide 60 sirolimus eluting stents 60 NMDA antagonists 60 parathyroidectomy 60 thromboembolic disease 60 thromboembolic complications 60 TNF α 60 TNF therapy 60 inotropic agents 60 mg kg dose 60 thyroglobulin 60 perioperative complications 60 induce remission 60 squamous cell lung cancer 60 CYP #D# 60 beta adrenergic 60 anti HBs 60 ADAMTS# 60 Fulvestrant 60 intravitreal injection 60 treprostinil 60 vasoactive 60 CMV infections 60 MMP inhibitors 60 immunomodulatory agents 60 certolizumab 60 florbetaben 60 remyelination 60 plasma uric acid 60 itraconazole 60 imatinib resistance 60 Pharmacokinetic studies 60 Amphinex ® 60 QT QTc 60 BH4 60 carotid IMT 60 prasugrel Effient 60 PLX cells 60 vessel occlusion 60 potentiation 60 NMDA antagonist 60 statins cholesterol lowering 60 estramustine 60 potentially hepatotoxic 60 rufinamide 60 antioxidant supplementation 60 epoetin beta 60 nadolol 60 percutaneous cryoablation 60 unstable angina pectoris 60 paraprotein 60 PASI scores 60 Clot busting 60 maximal dose 60 symptomatic intracranial 60 BrachySil TM 60 imexon 60 tachyarrhythmias 60 RSD# oral 60 Arranon 60 liver histology 60 thrombogenic 60 EGFR receptor 60 rHuEPO 60 anti coagulant therapy 60 piroxicam 60 adrenocorticotropic hormone 60 cerebral ischemia 60 adalimumab Humira 60 Ileus 60 Telintra 60 glycoprotein IIb IIIa inhibitors 60 transcranial Doppler 60 SERCA2a 60 antithrombotic therapies 60 achieved CCyR 60 imatinib therapy 60 liver resection 60 insulin secretagogues 60 Acute Ischemic Stroke 60 immune modulator 60 factor TNF 60 abacavir Ziagen 60 azelaic acid 60 cefotaxime 60 transcranial Doppler ultrasound 60 electrophysiologic 60 hematopoietic cancers 60 corticosteroid dose 60 MYLOTARG 60 Azacitidine 60 transthoracic 60 induced sputum 60 alicaforsen enema 60 Certolizumab pegol 60 complete cytogenetic response 60 tipranavir r 60 XZK 60 calcineurin inhibitor 60 postoperative atrial fibrillation 60 postmenopausal estrogen 60 lanreotide 60 cystoscopic 60 inecalcitol 60 stimulates insulin secretion 60 thiazide diuretic 60 ULORIC 60 RAS blockers 60 myocardial ischemia 60 Liver transplantation 60 sulphonylureas 60 COR Analyzer 60 thyroid stimulating hormone 60 ESBA# 60 revascularizations 60 antibody mediated 60 elevated creatinine 60 severe exacerbations 60 Immunosuppressive drugs 60 cisplatin resistant 60 erlotinib Tarceva 60 neoadjuvant therapy 60 platelet clumping 60 peginterferon 60 pharmacodynamic profile 60 PegIFN RBV 60 Acute renal failure 60 ribavirin therapy 60 tolterodine 60 immunosuppressive regimens 60 tranylcypromine 60 bronchodilatory 60 HDL Selective Delipidation 60 small molecule tyrosine 60 intra arterial 60 carotid artery stenosis 60 carcinoid 60 decompensated cirrhosis 60 dosing cohort 60 poststroke depression 60 STRIDE PD 60 NIASPAN 60 antihypertensive therapy 60 periprocedural 60 prodromal symptoms 60 dissolve clots 60 recurrent atrial fibrillation 60 Adjuvant therapy 60 Zevalin consolidation 60 desmopressin 60 splenectomized patients 60 adeno associated viruses 60 clodronate 60 atorvastatin #mg 60 pharmacologic stress 60 atherothrombotic events 60 intravenous immunoglobulin IVIg 60 IGFBP 3 60 colorectal adenoma 60 L dopa 60 hyperammonemia 60 Myelodysplastic Syndrome MDS 60 zotarolimus 60 tumor resection 60 KRAS mutation 60 EDEMA3 trial 60 HyQ 60 #mg dose [002] 60 administered subcutaneously 60 levodopa induced dyskinesia 60 endothelin antagonists 60 oral corticosteroid 60 BRINAVESS 60 dimeglumine 60 FOSRENOL ® 60 plasma renin activity 60 atherosclerotic disease 60 antidiabetic drugs 60 immunomodulatory therapy 60 dose dependently 60 desipramine 60 VTE prophylaxis 60 intravascular hemolysis 60 intraventricular 60 concomitant medications 60 ENMD # 60 NIHSS score 60 PRT# 60 ticagrelor Brilinta 60 acid suppressive therapy 60 durable remissions 60 potent anti angiogenic 60 prospective multicenter study 60 salmeterol fluticasone 60 aldosterone antagonist 60 NPM1 mutation 60 atrioventricular block 60 aneurysm rupture 60 inflammatory biomarkers 60 interferon γ 60 timepoints 60 postexposure prophylaxis 60 microdose 60 nicotinamide 60 EMSAM 60 hemodynamically unstable 60 pomalidomide 60 thiazide 60 Tumor Response 59 ovarian carcinoma 59 untreated OSA 59 status epilepticus 59 ischemia reperfusion 59 tolvaptan 59 plasmid encoding 59 clot busting 59 calcitriol 59 Kepivance 59 clot dissolving medication 59 #mg/day [002] 59 CD8 T cell 59 systemic corticosteroids 59 ZD# [001] 59 creatinine levels 59 caspofungin 59 hypervascular tumors 59 Riluzole 59 fondaparinux 59 irbesartan 59 IFN γ 59 intact parathyroid hormone 59 androgen suppression 59 idraparinux 59 overt nephropathy 59 ginkgo extract 59 TMP SMX 59 SCIg 59 chemoembolization 59 liposomal amphotericin B 59 intra articular injection 59 spontaneous regression 59 impair fertility 59 blood clotting protein 59 CT perfusion 59 myeloperoxidase 59 type 1diabetes 59 Xelox 59 Aptivus ® 59 docetaxel Taxotere ® 59 alpha blocker 59 tumor lysis syndrome 59 Gleevec imatinib 59 TNFa 59 aT cell 59 remission CR 59 chloride secretion 59 vecuronium 59 viral kinetics 59 treating neuropathic pain 59 EOquin R 59 Mitomycin C 59 antiandrogen 59 AMEVIVE 59 adverse cytogenetics 59 CLA supplementation 59 thrombotic thrombocytopenic purpura TTP 59 natriuretic peptides 59 dopamine partial agonist 59 neoplastic cells 59 oral prodrug 59 Gefitinib 59 bioprosthetic valve 59 carvedilol 59 MDCT scans 59 ImmunoVEX HSV2 59 coadministration 59 ASSERT trial 59 adenosine diphosphate ADP 59 epidural steroid injection 59 Eltrombopag 59 CD#c 59 topical testosterone 59 lenalidomide dexamethasone 59 immunomodulation 59 GRNCM1 59 NSCLC tumors 59 clot dissolving drugs 59 Th2 cytokines 59 milrinone 59 cervical lymph nodes 59 gastrointestinal absorption 59 Phe restricted diet 59 paroxysmal AF 59 N telopeptide 59 DACH platinum 59 microvessel 59 IL 1ß 59 QTc intervals 59 pDCs 59 Tacrolimus 59 levodopa carbidopa 59 PH# enzyme 59 antiangiogenic 59 FRAGMIN R 59 neoadjuvant chemotherapy 59 remifentanil 59 Torsades de Pointes 59 Unstable angina 59 HuMax EGFr 59 superficial bladder cancer 59 chronic idiopathic thrombocytopenic purpura 59 lung fibrosis 59 prochlorperazine 59 indomethacin 59 goserelin 59 Pharmacokinetics PK 59 QuadraSphere 59 biphasic 59 griseofulvin 59 microvessel density 59 activated partial thromboplastin 59 efalizumab 59 fibrin deposition 59 esophageal candidiasis 59 cardiovascular calcification 59 Venlafaxine 59 ATIR 59 APTIVUS ritonavir 59 dexmedetomidine 59 ACTH 59 zoledronate 59 repolarization 59 chlorambucil 59 XR NTX 59 pre operatively 59 azacitidine 59 pouchitis 59 TNF inhibitor 59 somatostatin analog 59 CYT# potent vascular disrupting 59 VEGF inhibitors 59 KRAS mutations occur 59 biliary tract cancer 59 cardioprotective effects 59 Thromboembolism 59 da mage 59 pharmacodynamic PD 59 cidofovir 59 AZILECT R 59 immune modulatory 59 ischemic cardiomyopathy 59 invasive angiography 59 Octreolin 59 mild hepatic impairment 59 adrenal function 59 motesanib 59 cis retinoic acid 59 glatiramer 59 symptomatic VTE 59 defibrotide 59 T1DM 59 GAMMAGARD 59 Factor VIIa 59 BEXXAR Therapeutic Regimen 59 quetiapine Seroquel 59 urothelial carcinoma 59 autoregulation 59 Pemetrexed 59 Trofex 59 microcirculatory 59 scintigraphic 59 pelvic lymphadenectomy 59 immunological responses 59 genotypic resistance 59 simvastatin ezetimibe 59 labetalol 59 HeFH 59 nelfinavir 59 unconjugated 59 PSMA ADC 59 thromboxane A2 59 IV bisphosphonates 59 circulating lymphocytes 59 Nesiritide 59 postoperative radiotherapy 59 serum urate 59 octreotide 59 pulmonary artery banding 59 moderately emetogenic 59 warfarin anticoagulation 59 ptau 59 LCP Tacro TM 59 tissue plasminogen activator 59 myocardial reperfusion 59 sodium stibogluconate 59 trial evaluating PRX# 59 ToGA 59 Kamada AAT 59 teriparatide 59 Noxafil 59 Neuropeptide Y 59 strontium ranelate 59 pelvic irradiation 59 Glypromate